Vigil Health Solutions Inc. ("Vigil") (TSX VENTURE:VGL) announces the results of
operations for the quarter ending June 30, 2013.


Business Highlights 



--  Record sales bookings of $1.60 million compared to $1.01 million in the
    three-month period ended June 30, 2012 
--  Revenue up 33% to $894 thousand compared to $673 thousand in the three-
    month period ended June 30, 2012 
--  Earnings of $21 thousand compared to a loss of $61 thousand in three-
    month period ended June 30, 2012 
--  Gross proceeds of $388 thousand from warrant exercise 



"We are pleased to have achieved record sales bookings this quarter. This is a
credit to the team's success with existing and new corporate clients. These
bookings, combined with continued growth in revenue and earnings, show the
progress we are making in the seniors housing space," stated Troy Griffiths,
President and CEO of Vigil Health Solutions Inc.


Financial Results 

Revenue for the three-months ended June 30, 2013 was $894 thousand compared to
$673 thousand in the three-month period ended June 30, 2012, an increase of 33%.
Project revenue made up 53% of total revenue; the remaining revenue came from
follow on sales to existing customers. These sales include service and
maintenance billings and replacement products including wireless devices and
communication equipment. 


Bookings for the quarter were $1.60 million up 58% compared to $1.01 million in
the three-month period ended June 30, 2012. 


At June 30, 2013 Vigil had a backlog of approximately $3.43 million (including
$1.28 million in deposits and progress billings, recorded as deferred revenue on
the balance sheet) a 47% increase compared to approximately $2.34 million
(including $684 thousand in deposits and progress billings, recorded as deferred
revenue on the balance sheet) at June 30, 2012. At June 30, 2013, Vigil's
backlog included 33 projects at varying stages of installation and progress
billing with an average size of $104 thousand. There were 30 projects with an
average size of $78 thousand in the three months ended June 30, 2012. 


The gross margin percentage for the three months ended June 30, 2013 was 53%
compared to 49% for the three months ended June 30, 2012. In addition to the
large number of one off sales that usually have better margins due to the lower
labour component, there were a number of projects with gross margin above
management's usual expectations of between 42% and 47%. This was due to a number
of factors including lower travel expenses and exclusion of the usually low
margin subcontractor labour from the majority of projects. 


Expenditures for the three months ended June 30, 2013 were $463 thousand, up 18%
from operating expenditures of $393 thousand for the period ended June 30, 2012.
The increase is primarily due to increased staffing costs. 


Earnings for the three month period ended June 30, 2013 were $21 thousand, or
$0.001 per share compared to a loss of $61 thousand, or $0.005 per share for the
previous year. The profitable quarter resulted from the increase in both revenue
and margins. 


Detailed financial statements along with Management Discussion and Analysis have
been filed with SEDAR (www.sedar.com).


Financial information will be mailed to entitled security holders on August 30,
2013, or, upon notice to the Company, entitled security holders may request a
copy of financials in advance.




Summary Financial Information                                               
                                                                            
----------------------------------------------------------------------------
----------------------------------------------------------------------------
                                                      June 30,     June 30, 
                                                          2013         2012 
----------------------------------------------------------------------------
                                                   (unaudited)  (unaudited) 
                                                                            
Revenue                                           $    893,897 $    673,228 
Cost of sales                                          423,098      341,916 
----------------------------------------------------------------------------
Gross profit                                           470,799      331,312 
Expenses                                               463,430      392,905 
----------------------------------------------------------------------------
Income (loss) before the following items                 7,369      (61,593)
Other income (expense):                                 13,132          296 
----------------------------------------------------------------------------
Comprehensive income (loss) for the period        $     20,501 $    (61,297)
----------------------------------------------------------------------------
----------------------------------------------------------------------------



Non-IFRS Measure

For the three months ended June 30, 2013, we are disclosing Adjusted EBITDA, a
non-IFRS financial measure, as a supplementary indicator of operating
performance. We define Adjusted EBITDA as net income before, interest, income
taxes, amortization, stock based compensation and currency gains or losses
including derivative foreign exchange differences. We are presenting the
non-IFRS financial measure in our filings because we use it internally to make
strategic decisions, forecast future results and to evaluate our performance and
because we believe that our current and potential investors and analysts use the
measure to assess current and future operating results and to make investment
decisions. It is a non-IFRS measure, may not be comparable to other companies
and it is not intended as a substitute for IFRS measures.


Adjusted EBITDA Reconciliation



----------------------------------------------------------------------------
----------------------------------------------------------------------------
                                                      Three months ended    
                                                     June 30,      June 30, 
                                                         2013          2012 
----------------------------------------------------------------------------
                                                                            
Income / (loss) for the period                   $     20,501  $    (61,297)
                                                                            
Add / (deduct)                                                              
  Foreign exchange gain (loss)                        (16,779)      (17,823)
  Derivative exchange gain (loss)                       2,902        13,500 
  Interest                                                745         4,027 
  Stock based compensation                              9,977           711 
  Amortization                                          3,504         4,417 
  --------------------------------------------------------------------------
                                                          349         4,832 
                                                                            
----------------------------------------------------------------------------
Adjusted EBITDA                                  $     20,850  $    (56,465)
----------------------------------------------------------------------------
----------------------------------------------------------------------------



About Vigil Health Solutions Inc. 

Vigil offers a proprietary technology platform combining software and hardware
to provide comprehensive solutions to the expanding seniors' housing market.
Vigil has established a growing presence in North America and an international
reputation for being on the leading edge of systems design and integration.
Vigil's objective is to offer solutions for the full continuum of care. Vigil's
product range includes the innovative wireless Vitality Care System(TM)
featuring discreet 'mini pendants', a nurse call system, mobile fall,
incontinence monitoring, resident check and the award-winning Vigil Dementia
System.


Certain statements contained in this news release that are not based on
historical facts may constitute forward-looking statements or forward-looking
information within the meaning of applicable securities laws ("forward-looking
statements"). These forward-looking statements are not promises or guarantees of
future performance but are only predictions that relate to future events,
conditions or circumstances or our future results, performance, achievements or
developments and are subject to substantial known and unknown risks,
assumptions, uncertainties and other factors that could cause our actual
results, performance, achievements or developments in our business or in our
industry to differ materially from those expressed, anticipated or implied by
such forward-looking statements.


Forward-looking statements include all financial guidance, disclosure regarding
possible events, conditions, circumstances or results of operations that are
based on assumptions about future economic conditions, courses of action and
other future events. We caution you not to place undue reliance upon any such
forward-looking statements, which speak only as of the date they are made. These
forward-looking statements appear in a number of different places in this
presentation and can be identified by words such as "may", "estimates",
"projects", "expects", "intends", "believes", "plans", "anticipates", or their
negatives or other comparable words. Forward-looking statements include
statements regarding the outlook for our future operations, plans and timing for
the introduction or enhancement of our services and products, statements
concerning strategies or developments, statements about future market
conditions, supply conditions, end customer demand conditions, channel inventory
and sell through, revenue, gross margin, operating expenses, profits, forecasts
of future costs and expenditures, the outcome of legal proceedings, and other
expectations, intentions and plans that are not historical fact.


The risk factors and uncertainties that may affect our actual results,
performance, achievements or developments are many and include, amongst others,
our ability to develop our sales force and generate revenue, the length of the
sales cycle, management of the Company's growth, ability to recruit and retain
staff, fluctuations in demand for current and future products, our ability to
develop, manufacture, supply and market existing and new products that meet the
needs of customers, volatility in the exchange rate, ability to secure
financing, ability to secure product liability insurance, the continuous
commitment of our customers, increased competition, changes in regulation and
reliance on third party suppliers. These risk factors and others are discussed
in the Risks and Uncertainties section of our "Management Discussion and
Analysis" segment of our fiscal 2013 Annual Report. Many of these factors and
uncertainties are beyond the control of the Company. Consequently, all
forward-looking statements in this news release are qualified by this cautionary
statement and there can be no assurance that actual results, performance,
achievements or developments anticipated by the Company will be realized. 


Forward-looking statements are based on management's current plans, estimates,
projections, beliefs and opinions and, except as required by law, the Company
does not undertake any obligation to update forward-looking statements should
the assumptions related to these plans, estimates, projections, beliefs and
opinions change.


The TSX Venture Exchange has not reviewed and does not accept responsibility for
the adequacy or accuracy of this release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Vigil Health Solutions Inc.
Troy Griffiths
President and CEO
(250) 383-6900
(250) 383-6999 (FAX)
information@vigil.com


Vigil Health Solutions Inc.
2102-4464 Markham Street
Victoria, BC
V8Z 7X8
www.vigil.com

Vigil Health Solutions (TSXV:VGL)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024 Vigil Health Solutions 차트를 더 보려면 여기를 클릭.
Vigil Health Solutions (TSXV:VGL)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024 Vigil Health Solutions 차트를 더 보려면 여기를 클릭.